• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

FDA inspection

FDA
Manufacturing

J&J subsidiary slapped with FDA warning letter

J&J's subsidiary landed in hot water with the FDA this summer over manufacturing problems at the company’s South Korean plant.
Fraiser Kansteiner Sep 23, 2025 2:22pm
FDA

Novo plant acquired in Catalent deal lands in FDA's crosshairs

Aug 22, 2025 10:49am
FDA stop sign

FDA snubs Ultragenyx gene therapy over manufacturing issues

Jul 14, 2025 10:16am
Asia

Enhertu, Takeda, Trump—Fierce Pharma Asia

May 9, 2025 6:15am
President Donald Trump speaks to reporters after signing a proclamation in the Oval Office at the White House on April 17 20

Trump, in exec order, tasks FDA with boosting US drug production

May 6, 2025 10:18am
FDA

Compounder in Lilly lawsuit hit with FDA warning letter

Apr 24, 2025 8:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings